textivf.com · Premium domain for sale

The AI that fights for IVF patients.

IVF is one of the most expensive, confusing purchases a family ever makes, and almost nobody negotiates on the patient's side. textivf.com is a short, memorable name for the company that does it by text message.

Buy it now$10,000One payment
Lease to own$500/month60 months ($30,000 total)
Own it for $10,000See the numbers

Why IVF, why now

Big, growing, expensive and opaque: the classic setup for an AI agent that works for the buyer.

449,772US IVF cycles in 2024, producing 100,158 babies (SART preliminary data) [1]
$23,474Average cost of one IVF cycle in the US (FertilityIQ) [3]
~2.5 cyclesAverage cycles per patient, roughly $50K all-in (FertilityIQ) [3]
~27%Share of patients whose treatment is fully covered by insurance (FertilityIQ) [3]

Tailwind: In October 2025 the White House announced IVF actions, including discounted fertility drugs from EMD Serono through TrumpRx and guidance letting employers offer stand-alone fertility benefits [4]. More coverage and more price transparency means more patients shopping, and more need for a guide.

Five business models

Each one can stand alone; together they compound.

  1. Model 1Vertical chat bot

    An IVF copilot you can text

    Build a vertical chat bot that helps people understand their clinic's quote line by line, compare clinics on success rates and price, and track meds, appointments and costs across every cycle.

    Revenue: consumer subscription ($19/month during treatment), CPC advertising from clinics and pharmacies, and CPL offers for financing, egg freezing and fertility benefits.

  2. Model 2AI bidding service

    Clinics bid for your cycle

    Patients share their plan once; the AI gathers cash-pay quotes from qualified clinics and negotiates price, add-ons and multi-cycle bundles, the way Priceline, Kayak and Thumbtack did for travel and home services.

    Revenue: patient-paid success fee of about 5% of the savings-adjusted booking. Fees are paid by the patient, not the clinic, to stay clear of anti-kickback and fee-splitting rules.

  3. Model 3Medication price finder

    Find the cheapest fertility meds

    Fertility drugs often cost over $5,000 per cycle, almost 20% of total treatment cost [4]. The bot compares specialty pharmacies, manufacturer programs and discount channels, then texts refill reminders. Progyny alone booked $437.7M of pharmacy revenue in 2024 [5].

    Revenue: affiliate and referral fees where lawful, a premium tier for auto-reorder, and pharmacy advertising.

  4. Model 4Financing marketplace

    Loans, refund plans and multi-cycle packages

    Match patients to IVF loans, refund-guarantee programs and shared-risk packages, explained in plain language with the real total cost.

    Revenue: CPL and funded-loan fees from lenders, plus program referral fees.

  5. Model 5Employer benefit navigator

    Fertility benefits for the companies that don't have them

    Sell a lightweight, text-first fertility navigator to small and mid-size employers using the new stand-alone benefit guidance, the segment Progyny, Carrot and Maven under-serve.

    Revenue: per-employee-per-month (PEPM) fees, plus care-navigation upsells.

Regulatory note: Referral payments in healthcare are restricted by federal and state anti-kickback and fee-splitting laws. Any operator should structure fees with counsel. Nothing on this page is medical advice.

Ways to drive traffic

Cost calculator SEO. Rank for "IVF cost in [city]" and "[clinic] price" with live, crowd-sourced quotes.
Text-to-start. "Text IVF to …" on every page, ad and podcast read; the domain is the call to action.
Community partners. Patient forums, Reddit, TikTok fertility creators and RESOLVE-style support groups.
Employer and HR channels. Benefits brokers and PEO partners selling Model 5.

Competitive analysis

Billions of venture and public-market dollars sit around IVF, almost all of it selling to employers or clinics. Nobody owns the patient-side, text-first negotiating agent.

CompanyWhat they doScale / fundingGap textivf.com can fill
ProgynyEmployer fertility benefit manager (public, PGNY)$1.17B revenue in 2024, incl. $437.7M pharmacy [5]Sells to large employers; patients can't buy it directly
Maven ClinicWomen's and family health platform$125M Series F, $1.7B valuation, Oct 2024 [6][13]Broad virtual care; fertility is one service line
Carrot FertilityGlobal fertility benefits$75M Series C led by Tiger Global, Aug 2021 [8]Employer-paid; no consumer price negotiation
KindbodyFertility clinic network + employer benefit$100M raise announced 2023 [7]Owns clinics, so it can't be a neutral price shopper
Future FamilyIVF financing, refund plans and care coachingCovered by Healthcare Brew, 2025 [12]Financing-first; closest to Model 4
Alife HealthAI tools for clinics and patients$22M Series A [11]Sells AI to clinics, not a patient-side agent
Conceivable Life SciencesAutomated, AI-run IVF lab (AURA)$50M Series A, $70M total, Sep 2025 [10]Lowers lab cost; a future partner, not a rival
GametoStem-cell egg-maturation therapy (Fertilo)$44M Series C, $127M total, Aug 2025 [9]Biotech; could shorten cycles and change pricing
FertilityIQClinic reviews, cost data, educationHigh-traffic patient resource [3]Information only; no booking, bidding or negotiation

Whitespace: only about 27% of US patients have their IVF treatment fee fully covered [3], and federal action is pushing drug prices and employer benefits into the open [4]. The cash-pay patient, spending around $50K across multiple cycles, has no agent on their side. That is the opening.

Total Addressable Market (TAM)

Sized the way a VC analyst would: top-down from third-party data, then checked bottom-up.

TAM$9.4B → $14.8BUS fertility services, 2023 to 2030, 6.7% CAGR (Grand View Research) [2]
SAM (our estimate)~$2.9BSelf-pay and partially covered IVF cycles plus fertility drugs that patients actively shop for, where an agent can earn a fee
SOM (target)$100M/yrAbout 1% of TAM, or ~3.5% of SAM, by Q4 2031

Bottom-up check

LineMathResult
US IVF cycle spend449,772 cycles [1] × ~$20K net per cycle (FertilityIQ average $23,474 [3], less covered portion)≈ $9.0B
Bidding fee pool$9.0B × 5% patient-paid fee≈ $450M
Fertility drug spend449,772 cycles × ~$5,000 in drugs [4]≈ $2.2B
Meds finder pool$2.2B × ~10% referral and subscription capture≈ $225M
Subscriptions~300K patients a year × 20% conversion × $19/mo × 6 months≈ $68M

SAM and capture rates are analyst estimates, not reported figures. Bottom-up pools (~$750M+ before financing and employer revenue) comfortably support a $100M SOM.

The path to $100M

Quarterly revenue from Q1 2027 to Q4 2031, reaching a $100M annual run rate. Profit assumes the business costs 20% of revenue to build and maintain. Illustrative, not a forecast.

$0M$5M$10M$15M$20M$25M20272028202920302031AI bidding 35%Chat bot subs + ads 20%Meds finder 15%Financing 15%Employer PEPM 15%$0M$5M$10M$15M$20M$25M20272028202920302031
Profit (80% margin after 20% cost to build and run)
YearRevenueProfit (80%)Exit run rate
2027$1.3M$1.0M$3M
2028$8.8M$7.0M$13M
2029$24.6M$19.7M$33M
2030$49.7M$39.7M$61M
2031$84.6M$67.7M$100M
Show all 20 quarters
QuarterRevenueProfit
2027 Q1$0.03M$0.03M
2027 Q2$0.16M$0.13M
2027 Q3$0.38M$0.31M
2027 Q4$0.72M$0.58M
2028 Q1$1.18M$0.95M
2028 Q2$1.77M$1.41M
2028 Q3$2.48M$1.99M
2028 Q4$3.33M$2.66M
2029 Q1$4.32M$3.45M
2029 Q2$5.44M$4.35M
2029 Q3$6.71M$5.37M
2029 Q4$8.13M$6.50M
2030 Q1$9.69M$7.75M
2030 Q2$11.41M$9.13M
2030 Q3$13.28M$10.62M
2030 Q4$15.30M$12.24M
2031 Q1$17.48M$13.99M
2031 Q2$19.83M$15.86M
2031 Q3$22.33M$17.87M
2031 Q4$25.00M$20.00M

The domain

Own textivf.com

One price, two ways to pay. No haggling.

Buy it now$10,000

One payment. Domain transferred to you once payment clears.

Buy for $10,000
Lease to own$500/month

60 months ($30,000 total). You use the domain from day one and own it outright after the final payment.

Lease for $500/month

Tell us you're interested

Or email support@namethatstartup.com directly.

Sources

  1. ASRM / SART: more than 100,000 IVF babies in a single year (2024 data)
  2. Grand View Research: U.S. fertility services market outlook, 2030
  3. FertilityIQ: the cost of IVF by city
  4. White House fact sheet: actions to lower IVF costs (Oct 16, 2025)
  5. Progyny fourth quarter and full-year 2024 results
  6. Maven Clinic $125M Series F (PR Newswire)
  7. Kindbody $100M new funding
  8. Carrot $75M Series C (Fierce Healthcare)
  9. Gameto $44M Series C (PR Newswire)
  10. Conceivable Life Sciences $50M Series A (GlobeNewswire)
  11. Alife Health $22M Series A
  12. Healthcare Brew: Future Family and refundable IVF
  13. Maven valuation at $1.7B (CNBC)

Other domains to consider in the IVF space:

Each name is for sale and has its own page.

Launch updates

Sign up to get updates when this startup launches.